A product can have several different clocks

A sermorelin purchase may involve a billing interval, a shipment schedule, a stated supply period and a pharmacy beyond-use date. Those dates answer different questions. A subscription charged every ten weeks does not, by itself, establish that every dispensed vial remains usable for that long or that every prescription follows the same schedule.

Start by copying each period into a separate line of the comparison. Record what is charged today, when another payment occurs, when another shipment is expected and what the pharmacy says about the preparation's use period. If a provider gives only one of those facts, leave the other fields unresolved rather than deriving them automatically.

Use the current label to identify the product

Regenics provides a concrete example: the reviewed storefront labels its injectable as 15 mg, while the URL contains 9mg. The address alone should not determine the quantity used in a comparison. Confirm the selected product, order confirmation and prescription, then resolve any disagreement with the provider and pharmacy before proceeding.

Total milligrams and concentration are also different measures. A total amount does not establish volume, and a concentration does not establish the total quantity without the container size. Neither fact alone gives a reader enough information to calculate an individualized administration plan. Keep product identification separate from instructions issued for a particular patient.

Four weeks is not a calendar month

GobyMeds uses month-based headings while specifying four- and twelve-week packages for its sermorelin products. Four weeks is twenty-eight days, which differs from most calendar months. That distinction can matter when comparing a package with a provider that bills on a fixed date each month or calculating the cost of continuing care.

Use the full package totals first: the injection and troche list $199 and $399, while the film lists $249 and $449. The $449 film package divided by three is approximately $149.67, despite a $149 headline. These calculations explain the advertised purchase; they do not establish how long an individual should receive treatment.

A member price needs its own conditions

Regenics displays a $159 member headline alongside a $399 standard price and a subscription labeled $399 every ten weeks. Without the membership requirements and actual invoice, those cues cannot be combined into a reliable continuing cost. Ask whether membership has a charge and which payment changes when the member offer applies.

Similarly, a one-time package with no automatic renewal is not a free continuing-care arrangement. Another order may involve another assessment and payment. Separate the cost of stopping a recurring agreement from the refund policy for medication already prepared, because those are different contractual events and may have different conditions.

Finish with the actual formulation and care plan

An injection, troche and oral film are distinct preparations. Do not use a price comparison, a shared ingredient or a package's total quantity to infer equivalent effects across routes. Each product needs its own prescription, storage information and explanation of the evidence relevant to the intended use.

The resulting worksheet should be understandable without a dosing calculation: exact product, full charge, payment interval, stated supply, shipment timing and unresolved questions. Bring that record to the clinical discussion. It helps prevent commercial shorthand from becoming an accidental treatment instruction while making the provider's financial terms easier to evaluate.

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. Regenics: sermorelin injectable listing and purchase choices Provider
  2. GobyMeds: sermorelin injection packages Provider
  3. GobyMeds: sermorelin troche packages Provider
  4. GobyMeds: sermorelin film strip packages Provider
  5. FDA: Understanding the Risks of Compounded Drugs Regulatory